Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arvida Group Limited Interim / Quarterly Report 2017

Nov 29, 2016

66157_rns_2016-11-29_4009e99e-83b8-4647-85f1-16a9aa3b451b.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

==> picture [39 x 39] intentionally omitted <==

Morgans Investor Day

Aged Care & Retirement Living

30 November 2016

==> picture [318 x 71] intentionally omitted <==

==> picture [39 x 39] intentionally omitted <==

WELCOME

==> picture [100 x 100] intentionally omitted <==

Bill McDonald, CEO Previously:

  • General Manager of ING’s retirement assets division in New Zealand

  • Regional Operations Manager for Stockland Limited in Victoria, Aust

==> picture [97 x 97] intentionally omitted <==

Jeremy Nicoll, CFO Previously:

  • CFO for ING Property Trust and ING Medical Properties Trust (renamed Argosy Property Limited and Vital Healthcare Property Trust respectively)

  • Managing Director of ING Real Estate and Managing Director of ING Insurance

2

==> picture [39 x 39] intentionally omitted <==

COMPELLING NZ MARKET DYNAMICS

Demographic demand underpins needs based growth

NZ’s Ageing Population (85+ years)

Shortage of Beds Looming

==> picture [667 x 202] intentionally omitted <==

----- Start of picture text -----

10k 180k 60k
9k 160k
8k 50k
140k
7k
120k 40k
6k
100k
5k 30k
80k
4k
3k 60k 20k
40k
2k
10k
1k 20k
- - k
2017 2020 2023 2026 2029 2032 2008 2011 2014 2017 2020 2023 2026
Change (LHS) Number (RHS) Existing Beds Build Rate Supply Gap
Total NZ Population Aged 85+ years
Additional persons entering aged bracket No. Care Beds (assuming 95% occupancy)
----- End of picture text -----

  • 80% increase in population aged 85+ years over next 15 years

  • Living longer/healthier leads to change in resident profile

  • Net increase in beds lags demand

  • 80-110% increase in capacity needed over next 10 years

Source: Ministry of Health, Statistics NZ.

3

==> picture [39 x 39] intentionally omitted <==

NZ AGED CARE MODEL

Arvida Model

==> picture [680 x 358] intentionally omitted <==

----- Start of picture text -----

RV Care
Resident Resident
Dementia
Hospital Govt
Rest Home
RV Operator RV Operator
Fees Fees
Services
Statutory Level of Care
Supervisor Accommodation Payment on Entry Payment on Exit
----- End of picture text -----

4

==> picture [39 x 39] intentionally omitted <==

WHO IS ARVIDA?

==> picture [290 x 348] intentionally omitted <==

 IPO in 2014 successfully raised $80m

  • Current market capitalisation of ~$385m

 Institutions represent ~25% of register

==> picture [99 x 98] intentionally omitted <==

75% Needs-Based Composition

85.5 years Resident Age

>2,700 Residents

>1,600 Staff

26 Villages[^] (24 with integrated care) 1,458/1,285 units/beds

^Conditional agreement to acquire Cascades announced 23 November 2016.

5

==> picture [39 x 39] intentionally omitted <==

OUR STRATEGY

The Attitude of Living Well

==> picture [34 x 32] intentionally omitted <==

==> picture [33 x 32] intentionally omitted <==

Development

Our vision is to improve the lives and wellbeing of our residents by transforming the ageing process

Brownfield development activity within existing villages

Greenfield over time where we see value

Our commitment is to challenge ourselves to make our residents’ lives better with everything we do

Acquisition

Stated Criteria: location, quality of assets and current management, opportunities for development and immediately earnings accretive

6

==> picture [39 x 39] intentionally omitted <==

ACTIVE DEVELOPMENT PROGRAMME

==> picture [650 x 393] intentionally omitted <==

----- Start of picture text -----

Consented Activity In Progress
Jonathan Ash 192/33 units/beds
Expected Date
GM Development First Resident
Copper Crest 40 Ongoing
 Localised project Oakwoods 22 Q1 FY18
management capability
established Aria Bay 24 Q3 FY18
 Right sized to current Park Lane 78 Q3 FY18
project pipeline
Rhodes on Cashmere 28 33 Q4 FY18
 Small in-house
Units Beds
development team
recently acquired Total Development Pipeline (incl. Consented)
Units 309
Beds 143
Other 100 Consented Planning
550+ development pipeline
Yet to be assessed
----- End of picture text -----

550+ development pipeline 20%+ increase in current portfolio

7

==> picture [39 x 39] intentionally omitted <==

PERFORMANCE TO DATE

Underlying Profit Per Share

Investment Property

==> picture [276 x 159] intentionally omitted <==

----- Start of picture text -----

3.46c
3.11c
2.93c
1H16 2H16 1H17
----- End of picture text -----

==> picture [339 x 191] intentionally omitted <==

----- Start of picture text -----

$358m
$295m
$273m
$212m
2H15 1H16 2H16 1H17
----- End of picture text -----

  • Top quartile EBITDA/Bed

  • Resale margins

  • “Fussy” in selecting assets to acquire

  • Prime growth areas

  • Procurement synergies

  • Integration of central support

systems

8

==> picture [39 x 39] intentionally omitted <==

OUTLOOK

Introduction of Care ORA

==> picture [263 x 146] intentionally omitted <==

----- Start of picture text -----

ROIC
----- End of picture text -----

Standard Care Bed

ORA

  • Stepped increase in ROIC

  • Same EBITDA

  • Minimal capex to convert

Integrated Care Model

==> picture [139 x 133] intentionally omitted <==

Captive Needs

  • Compelling demographics

  • Stability in cash flows

  • Needs-based/defensive

  • Care supports RV sales

  • Higher barriers to entry

9

==> picture [39 x 39] intentionally omitted <==

SECTOR POSITIONING

Portfolio Composition

==> picture [314 x 374] intentionally omitted <==

----- Start of picture text -----

(incl. % Needs Based)
10k
55%
8k
6k 19%
28%
75%
4k
2k
k
RYM MET SUM ARV
ILUs SAs Beds % Needs Based * Includes Cascades
Care Revenue Composition
100%
80%
60%
40%
20%
0%
RYM MET SUM ARV
FY14 FY15 FY16
Existing Units/Beds (No.)
Care Fees as a % of Revenue
----- End of picture text -----*

==> picture [350 x 206] intentionally omitted <==

----- Start of picture text -----

Market Landscape – Aged Care Beds
NZX Listed
14%
Arvida
4%
Small
Private/NFP Other
47% 14%
Bupa
Charitable 12%
9%
As a % of Beds, 2016.
----- End of picture text -----

Market Metrics

FY17
Gross Yield
P/NTA
ND/ND+E
ARV 5.1%
1.2x
9.6%
RYM
MET
SUM
2.1%
2.9x
32.5%
1.2%
1.0x
3.2%
1.6%
2.7x
37.2%

Source: Company Reports, Broker Reports, Ministry of Health

10

Appendix:

FINANCIAL RESULTS

==> picture [39 x 39] intentionally omitted <==

FINANCIAL HIGHLIGHTS

Underlying Profit

==> picture [334 x 131] intentionally omitted <==

----- Start of picture text -----

$9.6m
$8.5m
$7.3m
1H16 2H16 1H17
----- End of picture text -----

Underlying Profit per Share2

==> picture [334 x 117] intentionally omitted <==

----- Start of picture text -----

3.46c
3.11c
2.93c
1H16 2H16 1H17
----- End of picture text -----

  • Performance well ahead of last year

  • Underlying Profit up 31% on prior corresponding period

  • Strategy is delivering strong growth in underlying shareholder value

==> picture [191 x 191] intentionally omitted <==

  1. Calculated with reference to the average number of shares on issue over the period.

12

==> picture [39 x 39] intentionally omitted <==

INCOME STATEMENT (IFRS)

Six-months ending 30 September
Unaudited
(NZ$m)
Actual
First Half
FY2016
Actual
First Half
FY2017
Care & village service fees
Deferred management fees
Other revenue
Total revenue
Fair value movement of investment property
Total income
Operating expenses
Depreciation
Total expenses
34.6
40.1
3.6
5.0
1.0
1.8
39.2
49.9
3.8
14.3
43.0
61.2
(30.4)
(37.2)
(1.4)
(1.5)
(31.8)
(38.8)
Operating profit before financing, one-
off costs
11.2
22.4
Financing costs
One-off costs
Profit before income tax
Income taxation
(0.6)
(0.4)
(1.4)
(0.1)
9.3
21.8
(1.9)
(2.4)
Net profit after tax 7.4
19.4

Commentary:

  • Increased in fee revenue driven by acquisition strategy

  • Increase in DMF driven by acquisition strategy (circa 50%) and the balance through pricing strategy and resales

  • Care facilities revenue at $33.5m comprises 72% of total revenue

  • Fair value movement of Investment Properties assessed at $14.3m from desktop review completed by CBRE. Strong increases in Auckland and Rotorua villages

 Higher operating costs reflect a full period of Aria villages, Lansdowne Park for three months and continued reinvestment in staff and operations

13

==> picture [39 x 39] intentionally omitted <==

BALANCE SHEET

BALANCE SHEET
Six-months ending 30 September Actual Actual
Unaudited First Half First Half
(NZ$m) FY2016 FY2017
Cash and cash equivalents 1.1 1.7
Property, plant and equipment 110.6 123.2
Investment property 272.9 357.8
Goodwill 39.0 39.5
Other assets 12.2 15.0
TOTAL ASSETS 435.8 537.2
External debt 10.0 32.4
Residents’ loans 134.1 176.4
Deferred tax liability 15.5 16.7
Other liabilities 23.5 27.0
TOTAL LIABILITIES 183.1 252.5
NET ASSETS 252.7 284.7
Issued capital 246.6 252.6
Reserves 1.0 3.0
Retained earnings 5.1 29.1
TOTAL EQUITY 252.7 284.7

Commentary:

  • PP&E and Investment Property balances increased mainly due to Lansdowne Park acquisition, gains on revaluation and development work in progress

  • Debt increased to fund acquisition of Lansdowne Park and development activity

 Remains conservatively geared at 10% (post capital raise and October acquisition settlements), with headroom to fund planned development activity and the Cascades acquisition under the new $80m multi tranche facility

  • $6.0m of new shares issued during the period in relation to the Lansdowne Park transaction

14

==> picture [39 x 39] intentionally omitted <==

CASH FLOW

CASH FLOW
Six-months ending 30 September Actual Actual
Unaudited First Half First Half
(NZ$m) FY2016 FY2017
Receipts from residents for care fees and
village services
35.6 41.2
Residents’ loans 18.0 25.1
Repayment of residents’ loans (9.1) (11.4)
Payments to suppliers and employees (29.3) (35.5)
Other operating cash flows 0.1 -
Financing costs (0.5) (0.4)
Taxation (2.5) (3.7)
Net cash flow from operating activities 12.3 15.4
Purchase of investment property (4.7) (5.2)
Purchase of property, plant and equipment (1.4) (8.6)
Payments for investments in subsidiaries (29.2) (6.3)
Net insurance claim proceeds 17.8 -
Other investing activities - (0.3)
Net cash flow from investing activities (17.5) (20.4)
Net cash flow from financing activities 4.4 4.9
Net (decrease) / increase in cash (0.7) (0.0)
Opening cash balance 1.8 1.8
Closing cash balance 1.1 1.7

Commentary:

  • Increase in cash flow from fees and services driven by acquisition activity

  • $21.5m received from new residents over 87 resales and $3.6m received from 12 new sales

  • $11.4m paid to exiting residents

  • Main drivers of Investment Property addition is the acquisition of unit titles, Glenbrae development and adjoining site acquisitions

  • PPE cash flow mainly on development activity at Park Lane, Rhodes on Cashmere and Glenbrae

15

==> picture [39 x 39] intentionally omitted <==

RECONCILIATION TO UNDERLYING PROFIT[1]

RECONCILIATION TO UNDERL
Six-months ending 30 September
Unaudited
(NZ$m)
First Half
FY2016
First Half
FY2017
Net profit after tax 7.4
19.4
Less: Change in fair values (3.8)
(14.3)
Add: Deferred tax (0.4)
0.4
Add: One-off costs 1.4
0.1
Underlying operating profit 4.6
5.7
Add: Gains on resale of existing units 2.0
3.2
Add: Gain on sale of new units 0.7
0.7
Underlying profit 7.3
9.6

1 Underlying Profit is a non-GAAP measure and differs from NZ IFRS net profit after tax by replacing the fair value adjustment in investment property values with the Board’s estimate of realised components of movements in investment property value and to eliminate deferred tax and one-off costs.

Commentary:

  • Fair value change of $14.3m, deferred tax of $0.4m and transaction expenses of $0.1m removed from the calculation of Underlying Profit

  • Gains from 87 resales of existing units totalled $3.2m. The aggregate value of resales was $22.0m. This represents an average resale price of $252k and a resale margin of 15%

  • Development margins on 12 sales of new units totalled $0.7m. The aggregate value of new sales was $3.6m. This represents an average sale price of $296k and a sales margin of 19%

16